Clinical Trial Update: Macular Edema Ranibizumab v. Intravitreal Anti-inflammatory Therapy Trial [Phase 3]

View source ↗

Summary

Phase 3 trial comparing ranibizumab to intravitreal anti-inflammatory therapy in uveitis-associated macular edema has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Macular Edema
• Uveitis

Drugs mentioned

• Ranibizumab (ranibizumab)

Snippet

Sponsor: JHSPH Center for Clinical Trials | Conditions: Uveitis, Macular Edema | Phase 3 | Status: COMPLETED | Results posted: 2023-07-10